SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Nwe Ni Than, Philip N. Newsome, A concise review of non-alcoholic fatty liver disease, Atherosclerosis, 2015, 239, 1, 192

    CrossRef

  2. 2
    Brian C. Ferslew, Guoxiang Xie, Curtis K. Johnston, Mingming Su, Paul W. Stewart, Wei Jia, Kim L. R. Brouwer, A. Sidney Barritt, Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis, Digestive Diseases and Sciences, 2015,

    CrossRef

  3. 3
    S. Michail, M. Lin, M. R. Frey, R. Fanter, O. Paliy, B. Hilbush, N. V. Reo, Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease, FEMS Microbiology Ecology, 2015, 91, 2, 1

    CrossRef

  4. 4
    S.T. Tapia-Paniagua, S. Vidal, C. Lobo, I. García de la Banda, M.A. Esteban, M.C. Balebona, M.A. Moriñigo, Dietary administration of the probiotic SpPdp11: effects on the intestinal microbiota and immune-related gene expression of farmed Solea senegalensis treated with oxytetracycline, Fish & Shellfish Immunology, 2015,

    CrossRef

  5. 5
    Weiwei Jiang, Na Wu, Xuemei Wang, Yujing Chi, Yuanyuan Zhang, Xinyun Qiu, Ying Hu, Jing Li, Yulan Liu, Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease, Scientific Reports, 2015, 5, 8096

    CrossRef

  6. 6
    Venkatanarayana Gangarapu, Ali Tüzün Ince, Birol Baysal, Yusuf Kayar, Ulkan Klç, Özlem Gök, Ömer Uysal, Hakan Şenturk, Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease, European Journal of Gastroenterology & Hepatology, 2015, 27, 7, 840

    CrossRef

  7. 7
    Irina A. Kirpich, Luis S. Marsano, Craig J. McClain, Gut–liver axis, nutrition, and non-alcoholic fatty liver disease, Clinical Biochemistry, 2015,

    CrossRef

  8. You have free access to this content8
    Eamonn M.M. Quigley, Is the gut microbiota disturbed in chronic liver disease?, Clinical Liver Disease, 2015, 5, 4
  9. 9
    Won Sohn, Dae Won Jun, Kang Nyeong Lee, Hang Lak Lee, Oh Young Lee, Ho Soon Choi, Byung Chul Yoon, Lactobacillus paracasei Induces M2-Dominant Kupffer Cell Polarization in a Mouse Model of Nonalcoholic Steatohepatitis, Digestive Diseases and Sciences, 2015,

    CrossRef

  10. 10
    Cat. Buffet, Cam. Buffet, Les hépatopathies stéatosiques non alcooliques et le microbiote intestinal, Médecine des Maladies Métaboliques, 2015, 9, 3, 301

    CrossRef

  11. 11
    Guoxiang Xie, Chong-Zhi Wang, Chunhao Yu, Yunping Qiu, Xiao-Dong Wen, Chun-Feng Zhang, Chun-Su Yuan, Wei Jia, Metabonomic Profiling Reveals Cancer Chemopreventive Effects of American Ginseng on Colon Carcinogenesis inApcMin/+Mice, Journal of Proteome Research, 2015, 150710134922006

    CrossRef

  12. You have free access to this content12
    James H. Tabibian, Cyril Varghese, Steven P. O'Hara, Nicholas F. LaRusso, Microbiome-immune interactions and liver disease, Clinical Liver Disease, 2015, 5, 4
  13. 13
    Michael Fuchs, New Medical Treatment Strategies for Nonalcoholic Steatohepatitis, Current Treatment Options in Gastroenterology, 2015, 13, 2, 259

    CrossRef

  14. 14
    Ruchi Mathur, Gillian M Barlow, Obesity and the microbiome, Expert Review of Gastroenterology & Hepatology, 2015, 1

    CrossRef

  15. 15
    Francesca Romana Ponziani, Silvia Pecere, Antonio Gasbarrini, Veronica Ojetti, Physiology and pathophysiology of liver lipid metabolism, Expert Review of Gastroenterology & Hepatology, 2015, 1

    CrossRef

  16. 16
    F. W. D. Tai, W.-K. Syn, W. Alazawi, Practical approach to non-alcoholic fatty liver disease in patients with diabetes, Diabetic Medicine, 2015, 32, 8
  17. 17
    Erin K. Spengler, Rohit Loomba, Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis, Mayo Clinic Proceedings, 2015,

    CrossRef

  18. 18
    Simon T Hui, Brian W Parks, Elin Org, Frode Norheim, Nam Che, Calvin Pan, Lawrence W Castellani, Sarada Charugundla, Darwin L Dirks, Nikolaos Psychogios, Isaac Neuhaus, Robert E Gerszten, Todd Kirchgessner, Peter S Gargalovic, Aldons J Lusis, The genetic architecture of NAFLD among inbred strains of mice, eLife, 2015, 4,

    CrossRef

  19. 19
    Niels van Best, Peter L. Jansen, Sander S. Rensen, The gut microbiota of nonalcoholic fatty liver disease: current methods and their interpretation, Hepatology International, 2015, 9, 3, 406

    CrossRef

  20. 20
    Parth J Parekh, Luis A Balart, David A Johnson, The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease, Clinical and Translational Gastroenterology, 2015, 6, 6, e91

    CrossRef

  21. 21
    Mithun Sharma, Shasikala Mitnala, Ravi K. Vishnubhotla, Rathin Mukherjee, Duvvur N. Reddy, Padaki N. Rao, The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis, Journal of Clinical and Experimental Hepatology, 2015, 5, 2, 147

    CrossRef

  22. 22
    J Fernandes, W Su, S Rahat-Rozenbloom, T M S Wolever, E M Comelli, Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans, Nutrition & Diabetes, 2014, 4, 6, e121

    CrossRef

  23. 23
    Dina L. Halegoua-De Marzio, Jonathan M. Fenkel, Concepts and Treatment Approaches in Nonalcoholic Fatty Liver Disease, Advances in Hepatology, 2014, 2014, 1

    CrossRef

  24. 24
    Mitchell L Jones, Jorge G Ganopolsky, Christopher J Martoni, Alain Labbé, Satya Prakash, Emerging science of the human microbiome, Gut Microbes, 2014, 5, 4, 446

    CrossRef

  25. 25
    Jennifer E Lambert, Jill A Parnell, Jay Han, Troy Sturzenegger, Heather A Paul, Hans J Vogel, Raylene A Reimer, Evaluation of yellow pea fibre supplementation on weight loss and the gut microbiota: a randomized controlled trial, BMC Gastroenterology, 2014, 14, 1, 69

    CrossRef

  26. 26
    Herbert Tilg, Alexander R Moschen, Evolving therapies for non-alcoholic steatohepatitis, Expert Opinion on Drug Discovery, 2014, 9, 6, 687

    CrossRef

  27. 27
    Noémie Péan, Isabelle Doignon, Thierry Tordjmann, Gut microbiota and bile acids: An old story revisited (again), Clinics and Research in Hepatology and Gastroenterology, 2014, 38, 2, 129

    CrossRef

  28. 28
    Eveliina Munukka, Satu Pekkala, Petri Wiklund, Omid Rasool, Ronald Borra, Lingjia Kong, Xiaowei Ojanen, Shu Mei Cheng, Christophe Roos, Soile Tuomela, Markku Alen, Riitta Lahesmaa, Sulin Cheng, Gut-adipose tissue axis in hepatic fat accumulation in humans, Journal of Hepatology, 2014, 61, 1, 132

    CrossRef

  29. 29
    Bernd Schnabl, David A. Brenner, Interactions Between the Intestinal Microbiome and Liver Diseases, Gastroenterology, 2014, 146, 6, 1513

    CrossRef

  30. 30
    Caroline C. Duwaerts, Jacquelyn J. Maher, Mechanisms of Liver Injury in Non-Alcoholic Steatohepatitis, Current Hepatology Reports, 2014, 13, 2, 119

    CrossRef

  31. 31
    Federica Del Chierico, Daniela Gnani, Pamela Vernocchi, Andrea Petrucca, Anna Alisi, Bruno Dallapiccola, Valerio Nobili, Putignani Lorenza, Meta-Omic Platforms to Assist in the Understanding of NAFLD Gut Microbiota Alterations: Tools and Applications, International Journal of Molecular Sciences, 2014, 15, 1, 684

    CrossRef

  32. 32
    Katherine Bourzac, Microbiome: The bacterial tightrope, Nature, 2014, 516, 7529, S14

    CrossRef

  33. 33
    Benoit Chassaing, Lucie Etienne-Mesmin, Andrew T. Gewirtz, Microbiota-liver axis in hepatic disease, Hepatology, 2014, 59, 1
  34. 34
    Itishree Trivedi, Mary E. Rinella, NAFLD and Cardiovascular Disease: Can the Real Association Be Determined?, Current Hepatology Reports, 2014, 13, 2, 130

    CrossRef

  35. 35
    Miriam B. Vos, Nutrition, nonalcoholic fatty liver disease and the microbiome, Current Opinion in Lipidology, 2014, 25, 1, 61

    CrossRef

  36. 36
    Luc Biedermann, Karin Brülisauer, Jonas Zeitz, Pascal Frei, Michael Scharl, Stephan R. Vavricka, Michael Fried, Martin J. Loessner, Gerhard Rogler, Markus Schuppler, Smoking Cessation Alters Intestinal Microbiota, Inflammatory Bowel Diseases, 2014, 20, 9, 1496

    CrossRef

  37. 37
    Nicolás Velasco, Alvaro Contreras, Bruno Grassi, The mediterranean diet, hepatic steatosis and nonalcoholic fatty liver disease, Current Opinion in Clinical Nutrition and Metabolic Care, 2014, 17, 5, 453

    CrossRef

  38. 38
    Stela Celaj, Michael W Gleeson, Jie Deng, George A O'Toole, Thomas H Hampton, Martin F Toft, Hilary G Morrison, Mitchell L Sogin, Juan Putra, Arief A Suriawinata, James D Gorham, The microbiota regulates susceptibility to Fas-mediated acute hepatic injury, Laboratory Investigation, 2014, 94, 9, 938

    CrossRef

  39. 39
    Patrice D. Cani, When specific gut microbes reveal a possible link between hepatic steatosis and adipose tissue, Journal of Hepatology, 2014, 61, 1, 5

    CrossRef

  40. 40
    Pietro Vajro, Marco Poeta, Luca Pierri, Cristina Pizza, Roberta D’Aniello, Maria Sangermano, Grazia Massa, Giulia Paolella, Nutrition in the Prevention and Treatment of Abdominal Obesity, 2014,

    CrossRef

  41. 41
    Wendy R Russell, Lesley Hoyles, Harry J Flint, Marc-Emmanuel Dumas, Colonic bacterial metabolites and human health, Current Opinion in Microbiology, 2013, 16, 3, 246

    CrossRef

  42. 42
    Fabio Nascimbeni, Raluca Pais, Stefano Bellentani, Christopher Paul Day, Vlad Ratziu, Paola Loria, Amedeo Lonardo, From NAFLD in clinical practice to answers from guidelines, Journal of Hepatology, 2013, 59, 4, 859

    CrossRef

  43. 43
    Pietro Vajro, Claudia Mandato, Roberta D’Aniello, More on Current Evidences on Probiotics as a Novel Treatment for Non-Alcoholic Fatty Liver Disease, Hepatitis Monthly, 2013, 13, 8

    CrossRef

  44. 44
    Alexander R. Moschen, Susanne Kaser, Herbert Tilg, Non-alcoholic steatohepatitis: a microbiota-driven disease, Trends in Endocrinology & Metabolism, 2013, 24, 11, 537

    CrossRef

  45. 45
    Eamonn M Quigley, Howard P Monsour, The gut microbiota and the liver: implications for clinical practice, Expert Review of Gastroenterology & Hepatology, 2013, 7, 8, 723

    CrossRef

  46. 46
    Loek P. Smits, Kristien E.C. Bouter, Willem M. de Vos, Thomas J. Borody, Max Nieuwdorp, Therapeutic Potential of Fecal Microbiota Transplantation, Gastroenterology, 2013, 145, 5, 946

    CrossRef